Pleomorphic group of non-spore forming anaerobic Gram-negative (some weakly or variable staining) bacilli (see WebLinked image)
Genus Bacteroides formerly included the genera Porphyromonas and Prevotella
Bacteroides fragilis group
Non-fragilis Bacteroides (many species)
Abscess formation in normally sterile sites
Bacteremia
Intraabdominal infections: more than 80% caused by B. fragilis
Gynecological infections: polymicrobial anaerobic infections with B. fragilis frequently causing abscesses
Skin and soft tissue infections: most commonly associated with B. fragilis; Gram-negative anaerobes gain access to these sites via bites or trauma
Respiratory
tract: polymicrobial infections including non-fragilis Bacteroides
Normal flora of upper respiratory and gastrointestinal tract which are colonized in large numbers
Endogenous spread to normally sterile sites
Although Bacteroides fragilis is relatively minor member of the normal flora of the gastrointestinal tract, more than 80% of all intraabdominal infections are associated with B. fragilis
Surgical and trauma patients
Patients with spontaneous peritonitis
Virulence factors can be organized into three broad categories:
Fimbriae and agglutinins function as adhesins
Polysaccharide capsule
Lipopolysaccharide
Oxygen tolerance
Wide array of enzymes:
Specimen collection to avoid contamination with normal flora
Oxygen-free transport medium system
Avoid drying
Bacteroides spp. grow rapidly (within two days) but most other anaerobes are slow growers on selective media
B. fragilis are resistant to kanamycin, vancomycin and colistin
B. fragilis growth is stimulated in the presence of 20% bile
Surgical drainage of abscess(es) and removal of necrotic tissue(s)
Long-term course of antibiotics
Prophylatic use of antibiotics
Virulence of Polysaccharide Capsule of Bacteroides fragilis
|
||||
DESCRIPTION
|
BIOLOGICAL
MATERIAL |
INFECTION
METHOD |
DISEASE
OBSERVED |
ORGANISMS
ISOLATED |
MIXED
|
Fecal Pellet
|
Intraperitoneal
Injection (Simulates intraabdominal infection) |
Peritonitis
or |
E. coli,
Enterococcus, Bacteremia |
Intraabdominal
Abscess |
B. fragilis
|
|||
MIXED
|
Nonencapsulated
B. fragilis + Enterococcus |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
+ Enterococcus |
MIXED
|
Encapsulated
B. fragilis + Enterococcus |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
|
LIVE
|
Encapsulated
B. fragilis |
IP Injection
|
Intraabdominal
Abscess |
B. fragilis
|
LIVE
CONTROL |
Encapsulated
Streptococcus pneumoniae |
IP Injection
|
No Disease
|
---
|
LIVE
CONTROL |
Enterococcus
|
IP Injection
|
No Disease
|
---
|
LIVE
|
Nonencapsulated
B. fragilis |
IP Injection
|
No Disease
|
---
|
DEAD
|
Heat-killed
Encapsulated B. fragilis |
IP Injection
|
Intraabdominal
Abscess |
Sterile
|
SUBUNIT
|
Purified
B. fragilis Capsule |
IP Injection
|
Intraabdominal
Abscess |
Sterile
|
SUBUNIT
CONTROL |
Purified
E. coli Capsule |
IP Injection
|
No Disease
|
---
|
Lecture Syllabus | General Course Information | Grade Determination |
Laboratory Syllabus | Interesting WebSite Links | Lab Safety |